Heckman Karin L, Estevez Ana Y, DeCoteau William, Vangellow Stephanie, Ribeiro Samantha, Chiarenzelli Joseph, Hays-Erlichman Bonnie, Erlichman Joseph S
Department of Biology, St. Lawrence University, Canton, NY, United States.
Department of Psychology, St. Lawrence University, Canton, NY, United States.
Front Pharmacol. 2020 Jan 28;10:1599. doi: 10.3389/fphar.2019.01599. eCollection 2019.
Cerium oxide nanoparticles (CeNPs) exhibit redox capacity with efficacy in disease models of oxidative stress. Here we compare, in parallel, three CeNP formulations with distinct chemical stabilizers and size. assays revealed antioxidant activity from all the CeNPs, but when administered to mice with a reactive oxygen species (ROS) mediated model of multiple sclerosis, only custom-synthesized Cerion NRx (CNRx) citrate-EDTA stabilized CeNPs provided protection against disease. Detectable levels of ceria and reduced ROS levels in the brains of CNRx CeNP-treated mice imply that these CeNPs' unique properties influence tissue distribution and subsequent biological activity, suggesting why differing CeNP formulations yield different effects in various models. Further, the variation in vs results with these CeNP formulations highlights the necessity for studies that confirm whether the inherent catalytic activity of CeNPs is maintained after transport and distribution within intact biological systems.
氧化铈纳米颗粒(CeNPs)具有氧化还原能力,在氧化应激疾病模型中具有疗效。在此,我们同时比较了三种具有不同化学稳定剂和尺寸的CeNP制剂。检测显示所有CeNPs都具有抗氧化活性,但当将其应用于患有活性氧(ROS)介导的多发性硬化症模型的小鼠时,只有定制合成的Cerion NRx(CNRx)柠檬酸盐-EDTA稳定的CeNPs能提供疾病保护作用。在接受CNRx CeNP治疗的小鼠大脑中可检测到二氧化铈水平且ROS水平降低,这意味着这些CeNPs的独特性质会影响组织分布及后续生物活性,这也解释了为何不同的CeNP制剂在各种模型中会产生不同的效果。此外,这些CeNP制剂在[具体指标]与[另一具体指标]结果上的差异凸显了开展研究以确认CeNPs的固有催化活性在完整生物系统内运输和分布后是否得以维持的必要性。